Insmed Analyst Ratings
H.C. Wainwright Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90
Insmed's Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition
FTAI Aviation Analyst Ratings
BTIG Initiates FTAI Aviation(FTAI.US) With Buy Rating, Announces Target Price $140
Benchmark Co. Maintains FTAI Aviation(FTAI.US) With Buy Rating, Raises Target Price to $150
FTAI Aviation Analyst Ratings
Morgan Stanley Maintains FTAI Aviation(FTAI.US) With Buy Rating, Raises Target Price to $140
Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities
Insmed Analyst Ratings
Truist Financial Reaffirms Their Buy Rating on Insmed (INSM)
Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition
Insmed (INSM) Receives a Buy From Morgan Stanley
Insmed Analyst Ratings
Insmed's Promising Outlook: Buy Rating Backed by Arikayce Performance and Brenso Launch Potential
Strong Arikayce Sales and Promising Clinical Advancements Bolster Buy Rating for Insmed
Analysts Offer Insights on Industrial Goods Companies: Rockwell Automation (ROK), FTAI Aviation (FTAI) and AerSale Corporation (ASLE)
FTAI Aviation Analyst Ratings
Stifel Upgrades FTAI Aviation(FTAI.US) to Buy Rating, Raises Target Price to $132
FTAI Aviation Price Target Maintained With a $100.00/Share by Benchmark